14 May 2025

biodrook recognized by Forbes as one of the 25 most promising tech startups in Ukraine

The biodrook team is proud to announce that our project has been recognized by Forbes as one of the 25 most promising technology startups in Ukraine. This achievement highlights the importance of our mission — to deliver fast, accessible, and innovative solutions for regenerative medicine.
biodrook focuses on the production of 3D-printed bone implants that gradually transform into the patient’s own bone tissue. Our solutions are designed to support medical institutions treating bone defects, with a particular emphasis on serving military patients. Thanks to both mobile and stationary manufacturing platforms, we’ve reduced implant production time to just 48 hours, enabling us to quickly respond to needs even in the most remote areas of the country.
The company continues to grow rapidly as we prepare to scale up production in Ukraine and enter international markets. Our partners — including Biopharma, The Mount Sinai Health System, DSM, and EVONIK — support our efforts to implement cutting-edge technologies in Ukraine and integrate them into healthcare systems across the EU and the United States.
We are grateful to Forbes for this recognition and for supporting innovations that are transforming the medicine of today and tomorrow. We remain committed to making advanced medical technologies accessible to everyone who needs them.
Follow our updates — we are only at the beginning of a much bigger journey in regenerative medicine.